Metastatic Castration-resistant Prostate Cancer, MCRPC: 503 Clinical Trials, Page 31 of 51

Hide Studies Not Open or Pending

307

sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Condition(s):Castration Levels of Testosterone; Castration-Resistant Prostate Carcinoma; Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents; Metastatic Prostate Adenocarcinoma; Progressive Disease; Prostate Carcinoma Metastatic in the Bone; Prostate Carcinoma Metastatic in the Soft Tissue; PSA Progression; Stage IVB Prostate Cancer AJCC v8; Testosterone Less Than 50 ng/dLLast Updated:April 27, 2022Active, not recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.